TY - JOUR
T1 - Solid variant of papillary thyroid carcinoma
T2 - Incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior
AU - Nikiforov, Yuri E.
AU - Erickson, Lori A.
AU - Nikiforova, Marina N.
AU - Caudill, Christy M.
AU - Lloyd, Ricardo V.
PY - 2001
Y1 - 2001
N2 - Solid variant is a rare and poorly characterized variant of papillary thyroid carcinoma. In this study we analyzed 20 primary cases of the solid variant of papillary carcinoma found in a series of 756 papillary carcinomas operated at the Mayo Clinic between 1962 and 1989. The criteria for classification included predominantly (>70%) solid growth pattern of primary tumor, retention of cytologic features typical of papillary carcinoma, and absence of tumor necrosis. For each case of the solid variant, a control case of classical papillary carcinoma matched by age, sex, tumor size, and length of follow-up was selected. The follow-up ranged from 6 to 32 years. Two patients with the solid variant of papillary carcinoma (10%) died from disease 7 and 10 years after initial surgery, while another two patients (10%) are alive with lung metastases. In contrast, the control group had no cases with distant metastases or death from disease. Molecular analyses showed a similar prevalence of RET/PTC rearrangements in both groups. In conclusion, the solid variant of papillary carcinoma is associated with a slightly higher frequency of distant metastases and less favorable prognosis than classical papillary carcinoma. However, it should be distinguished from poorly differentiated thyroid carcinoma, which has a reported lower survival rate compared with the solid variant of papillary carcinoma.
AB - Solid variant is a rare and poorly characterized variant of papillary thyroid carcinoma. In this study we analyzed 20 primary cases of the solid variant of papillary carcinoma found in a series of 756 papillary carcinomas operated at the Mayo Clinic between 1962 and 1989. The criteria for classification included predominantly (>70%) solid growth pattern of primary tumor, retention of cytologic features typical of papillary carcinoma, and absence of tumor necrosis. For each case of the solid variant, a control case of classical papillary carcinoma matched by age, sex, tumor size, and length of follow-up was selected. The follow-up ranged from 6 to 32 years. Two patients with the solid variant of papillary carcinoma (10%) died from disease 7 and 10 years after initial surgery, while another two patients (10%) are alive with lung metastases. In contrast, the control group had no cases with distant metastases or death from disease. Molecular analyses showed a similar prevalence of RET/PTC rearrangements in both groups. In conclusion, the solid variant of papillary carcinoma is associated with a slightly higher frequency of distant metastases and less favorable prognosis than classical papillary carcinoma. However, it should be distinguished from poorly differentiated thyroid carcinoma, which has a reported lower survival rate compared with the solid variant of papillary carcinoma.
KW - Papillary carcinoma
KW - RET/PTC
KW - Solid variant
KW - Thyroid
UR - http://www.scopus.com/inward/record.url?scp=0035186167&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035186167&partnerID=8YFLogxK
U2 - 10.1097/00000478-200112000-00002
DO - 10.1097/00000478-200112000-00002
M3 - Article
C2 - 11717536
AN - SCOPUS:0035186167
SN - 0147-5185
VL - 25
SP - 1478
EP - 1484
JO - American Journal of Surgical Pathology
JF - American Journal of Surgical Pathology
IS - 12
ER -